These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
863 related articles for article (PubMed ID: 18167178)
1. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. Zou BC; Dong L; Wang Y; Wang SH; Cao MB Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178 [TBL] [Abstract][Full Text] [Related]
2. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models. Xu JR; Luo JY; Shang L; Kong WM Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336 [TBL] [Abstract][Full Text] [Related]
3. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome]. Zhu J; Luo HS; Chen L; Zhou T Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2713-7. PubMed ID: 20137275 [TBL] [Abstract][Full Text] [Related]
4. Alternation of substance P-containing neural pathways in a rat model of irritable bowel syndrome with rectal distension. Wang WF; Yang YS; Peng LH; Sun G Chin J Dig Dis; 2006; 7(4):211-8. PubMed ID: 17054583 [TBL] [Abstract][Full Text] [Related]
5. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. Ren TH; Wu J; Yew D; Ziea E; Lao L; Leung WK; Berman B; Hu PJ; Sung JJ Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G849-56. PubMed ID: 17110521 [TBL] [Abstract][Full Text] [Related]
6. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639 [TBL] [Abstract][Full Text] [Related]
7. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome]. Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369 [TBL] [Abstract][Full Text] [Related]
8. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS). Zou N; Lv H; Li J; Yang N; Xue H; Zhu J; Qian J Transl Res; 2008 Dec; 152(6):283-9. PubMed ID: 19059163 [TBL] [Abstract][Full Text] [Related]
9. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712 [TBL] [Abstract][Full Text] [Related]
10. Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models. Chen Y; Li Z; Yang Y; Lin L; Zhang H Int J Mol Med; 2013 Mar; 31(3):607-13. PubMed ID: 23338623 [TBL] [Abstract][Full Text] [Related]
11. Visceral hypersensitivity in irritable bowel syndrome. Kanazawa M; Hongo M; Fukudo S J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723 [TBL] [Abstract][Full Text] [Related]
12. [Role of serotonin in the pathophysiology of the irritable bowel syndrome]. Moskwa A; Boznańska P Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model. Tamaoki S; Yamauchi Y; Nakano Y; Sakano S; Asagarasu A; Sato M J Pharmacol Exp Ther; 2007 Sep; 322(3):1315-23. PubMed ID: 17540858 [TBL] [Abstract][Full Text] [Related]
14. Expression of aquaporin 8 in colonic epithelium with diarrhoea-predominant irritable bowel syndrome. Wang JP; Hou XH Chin Med J (Engl); 2007 Feb; 120(4):313-6. PubMed ID: 17374283 [TBL] [Abstract][Full Text] [Related]
15. [Effect of Weichang Anwan on NO and 5-HT in blood serum, SP and MC in colon in IBS-D rats]. Hu R; Tang F Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(23):3073-7. PubMed ID: 20222427 [TBL] [Abstract][Full Text] [Related]
16. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466 [TBL] [Abstract][Full Text] [Related]
17. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders]. Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis. Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227 [TBL] [Abstract][Full Text] [Related]
19. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Rahimi R; Nikfar S; Abdollahi M Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]